Directly Observed Therapy (Dot) Log - 12 Dose Isoniazid-Rifapentine - Virginia

Directly Observed Therapy (Dot) Log - 12 Dose Isoniazid-Rifapentine - Virginia

Directly Observed Therapy (Dot) Log - 12 Dose Isoniazid-Rifapentine is a legal document that was released by the Virginia Department of Health - a government authority operating within Virginia.

FAQ

Q: What is Directly Observed Therapy (DOT)?
A: Directly Observed Therapy (DOT) is a method of monitoring and ensuring that people with tuberculosis (TB) take their medication as prescribed.

Q: What is a DOT log?
A: A DOT log is a record that tracks the administration of medication during Directly Observed Therapy.

Q: What is Isoniazid-Rifapentine?
A: Isoniazid-Rifapentine is a combination medication used for the treatment of latent tuberculosis infection.

Q: How many doses of Isoniazid-Rifapentine are in a 12 Dose regimen?
A: A 12 Dose Isoniazid-Rifapentine regimen consists of 12 doses of medication.

ADVERTISEMENT

Form Details:

  • Released on March 1, 2019;
  • The latest edition currently provided by the Virginia Department of Health;
  • Ready to use and print;
  • Easy to customize;
  • Compatible with most PDF-viewing applications;
  • Fill out the form in our online filing application.

Download a fillable version of the form by clicking the link below or browse more documents and templates provided by the Virginia Department of Health.

Download Directly Observed Therapy (Dot) Log - 12 Dose Isoniazid-Rifapentine - Virginia

4.4 of 5 (17 votes)
  • Directly Observed Therapy (Dot) Log - 12 Dose Isoniazid-Rifapentine - Virginia, Page 1
ADVERTISEMENT